ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

The Synergistic Effect of Class II HLA Epitope-Mismatch and Non-Adherence on Acute Rejection and Graft Survival

C. Wiebe,1,2 T. Nevins,3 W. Robiner,3,4 W. Thomas,5 A. Matas,6 P. Nickerson.1,2,8

1Medicine, University of Manitoba, Winnipeg, MB, Canada
2Transplant Immunology, Diagnostic Services of Manitoba, Winnipeg, MB, Canada
3Pediatrics, University of Minnesota, Minneapolis, MN
4Medicine, University of Minnesota, Minneapolis, MN
5Public Health, University of Minnesota, Minneapolis, MN
6Surgery, University of Minnesota, Minneapolis, MN
7Immunology, University of Manitoba, Winnipeg, MB, Canada.

Meeting: 2015 American Transplant Congress

Abstract number: B100

Keywords: Epitopes, HLA matching, Renal failure

Session Information

Session Name: Poster Session B: Kidney Complications: Late Graft Failure

Session Type: Poster Session

Date: Sunday, May 3, 2015

Session Time: 5:30pm-6:30pm

 Presentation Time: 5:30pm-6:30pm

Location: Exhibit Hall E

Predicting long-term outcomes in renal transplant recipients is essential to optimize medical therapy and determine the frequency of post-transplant pathologic and serologic monitoring. Non-adherence and HLA mismatch are risk factors that have been associated with poor long-term outcomes and may help individualize care. In the present study class II HLA mismatches were determined at the HLA epitope level in 195 renal transplant recipients in whom medication adherence was prospectively measured using electronic monitors in medication vial caps. Recipients were grouped by medication adherence and high (≥10 HLA-DR, ≥17 HLA-DQ) or low epitope-mismatch load. We found that the combination of higher epitope mismatch and poor adherence acted synergistically to determine the risk of rejection or graft loss.Non-adherent recipients with HLA-DR epitope mismatch ≥10 had increased graft loss (35% vs. 8%, p<0.01) compared to adherent recipients with low epitope mismatch. At the HLA-DQ locus non-adherent recipients with HLA-DQ epitope mismatch ≥17 had increased graft loss (33% vs. 10%, p<0.01) compared to adherent recipients with low epitope mismatch. Subclinical non-adherence early post-transplant combined with HLA class II epitope mismatch may help identify recipients that could benefit from increased clinical, pathologic, and serologic monitoring.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Wiebe C, Nevins T, Robiner W, Thomas W, Matas A, Nickerson P. The Synergistic Effect of Class II HLA Epitope-Mismatch and Non-Adherence on Acute Rejection and Graft Survival [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/the-synergistic-effect-of-class-ii-hla-epitope-mismatch-and-non-adherence-on-acute-rejection-and-graft-survival/. Accessed May 28, 2025.

« Back to 2015 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences